ArticleScience translational medicine2023

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis.

Diane E Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.